A study about treatment of endometrium using autologous platelet rich plasma in patient suffering repeated implantation failure

A double-blind randomized control trial of autologous platelet-rich plasma in treatment of endometrium in repeated implantation failure patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003375

Enrollment

Registered

2018-11-25

Start date

2018-06-12

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Biological/Vaccine, Non-Stem Cell, Procedure/Surgery : 0.3~0.5ml of autologous PRP instillation to endometrial cavity 3 days before the embryo transfer in experimental group embryo culture media ins

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women want to IVF procedure aging 20~44 years 2. women failed to pregnancy despite two previous good quality of embryo transplatation

Exclusion criteria

Exclusion criteria: 1. Hgb <10.0 PLT < 130,000 or other hematologic disease 2. Need to treatment for for pregnancy to uterine-pelvic reason - uterine anomaly - intrauterine adhesion or synechia - submucosal myoma - adenomyosis diffusely involving whole myometrium - Severe endometriosis with Stage 3- 4 3. Body mass index>30kg/m2 4. NK cell >12, or denying PGT-A with chromosomal abnormality of patient/spouse

Design outcomes

Primary

Measure	Time frame
Clinical Pregnancy rate	—

Secondary

Measure	Time frame
positive ß-hCG , endometrial thickness	—

Countries

Korea, Republic of

Contacts

Public ContactHounyoung Kim

Bundang CHA General Hospital

kyril98@chamc.co.kr+82-31-780-5200

Outcome results